FDA Office of Generic Drugs
This article was originally published in The Tan Sheet
Executive Summary
Robert Pollock named acting deputy director, effective Oct. 18. Pollock will continue in his role as director of the Division of Labeling and Program Support. Pollock will be working with OGD Acting Director Douglas Sporn, who had doubled as deputy director. In an interoffice memo, Sporn said he was bringing Pollock in to assist with the office workload "over the next few months".